Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tectonic family member 3 (TCTN3) is a single-pass membrane protein localized at the ciliary transition zone, where it is an essential component of protein complexes involved in tissue-specific ciliogenesis and the regulation of ciliary membrane composition. It is required for proper Sonic Hedgehog (SHH) signal transduction and plays a critical role in neural tube development. Mutations in TCTN3 are linked to human ciliopathies including orofaciodigital syndrome IV and Joubert syndrome 18, leading to a wide range of developmental defects such as craniofacial abnormalities, brain anomalies, congenital heart disease, and neural tube defects. Loss of TCTN3 disrupts SHH signaling and may also interfere with apoptosis regulation via the PI3K/Akt pathway. No direct evidence is available to indicate TCTN3 is a current therapeutic drug target, nor are there known drugs that target it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tectonic family member 3 (TCTN3).